<DOC>
	<DOCNO>NCT02419846</DOCNO>
	<brief_summary>This clinical trial study inform decision make intervention screen prostate cancer predominantly African American participant . It also evaluate participant ' knowledge prostate cancer screen improve understanding . Using decision aid culturally sensitive write material , verbal information , videos educate patient screen may increase patient participation knowledge . This may increase confidence participant ' decision . Raising awareness prostate cancer community may increase participant ' willingness screen prostate cancer learn .</brief_summary>
	<brief_title>Informed Decision Making Intervention Screening Prostate Cancer Predominantly African American Participants Community Outreach Program</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : ( A ) To assess effectiveness propose educational model inform decision Prostate Cancer high risk men age 40 compare inform decision make share decision making ( B ) improve knowledge prostate cancer men age 18 OUTLINE : Participants complete educational intervention comprise 10-20 minute PowerPoint presentation give experience healthcare professional discus prostate cancer fact , screen guideline , risk , benefit , consequence . Some participant undergo screen exam comprise prostate specific antigen level digital rectal exam . After completion study , participant follow periodically .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Men age 18 ask participate educational component program ; men age 40 offer screen component educational portion event ; participant age 40 opportunity make inform decision regard prostate cancer screen base information educational material ; American Cancer Society ( ACS ) guideline recommend discussion screen men expect mortality great 10 year ; data comorbidities 10year mortality collect every participant use University California San Francisco ( UCSF ) mortality index Educational component : men age 18 Screening component : men age 40 Known personal history prostate cancer Active malignancy , metastatic disease , anyone undergoing treatment malignancy</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Informed Decision Making</keyword>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
</DOC>